Regulation of multidrug resistance in pathogenic fungi

Area of Science:

• Medical Mycology
• Molecular Biology
• Drug Discovery

Background:

• Opportunistic fungal infections (e.g., Candida, Cryptococcus, Aspergillus) are a significant threat, particularly in immunocompromised individuals.
• Antifungal drug resistance is a growing clinical problem, limiting treatment options.
• Efflux pumps, including ABC transporters and major facilitators, are key mechanisms conferring resistance to multiple antifungal agents.

Purpose of the Study:

• To review the current understanding of efflux pump-mediated drug resistance in human-pathogenic fungi.
• To highlight the role of efflux pumps in conferring resistance to antifungal therapies.
• To discuss the regulation of these efflux pumps and their implications for clinical treatment.

Main Methods:

• Literature review of studies on fungal drug resistance mechanisms.
• Analysis of research on efflux pump identification and characterization in pathogenic fungi.
• Synthesis of information on the genetic and regulatory factors controlling efflux pump expression.

Main Results:

• Efflux pump overexpression is a major mechanism of antifungal drug resistance in fungi like Candida albicans and Candida glabrata.
• Specific transporters and regulatory elements involved in resistance have been identified in some fungal species.
• The role of efflux pumps in resistance is less understood for other clinically relevant fungal pathogens.

Conclusions:

• Efflux pumps are critical mediators of antifungal drug resistance in human pathogens.
• Further research is needed to fully elucidate the role and regulation of efflux pumps in less-studied fungal species.
• Understanding efflux pump mechanisms is crucial for developing novel strategies to combat antifungal resistance.